about
Adipokines and Migraine: A Systematic ReviewCalcitonin gene-related peptide: A molecular link between obesity and migraine?Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment.Metabolic syndrome and migraine.Adiponectin and leptin levels in migraineurs in the Atherosclerosis Risk in Communities Study.Body mass index and adult weight gain among reproductive age women with migraine.Ictal adipokines are associated with pain severity and treatment response in episodic migraineSleep disturbances among pregnant women with history of migraines: A cross-sectional studyIctal adiponectin levels in episodic migraineurs: a randomized pilot trial.An Observational Study on the Association between Migraines and Tension Type Headaches in Patients Diagnosed with Metabolic Syndrome.Lifetime prevalence and correlates of migraine among women in a pacific northwest pregnancy cohort study.Migraine and obesity: epidemiology, mechanisms, and implications.Self-reported vs measured body mass indices in migraineursObesity and headache: Part II--potential mechanism and treatment considerations.The link between obesity and migraine in childhood: a systematic review.Obesity and headache/migraine: the importance of weight reduction through lifestyle modifications.Migraine and metabolism.Lifestyle Factors and Migraine in Childhood.Association of pediatric obesity and migraine with comparison to tension headache and samples from other countries.Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women.GLP-2 and leptin are associated with hyperinsulinemia in non-obese female migraineurs.Serum levels of adiponectin, CCL3/MIP-1α, and CCL5/RANTES discriminate migraine from tension-type headache patients.Enteric parasites can disturb leptin and adiponectin levels in children.Role of adipocytokines in the pathophysiology of migraine. A cross-sectional study.The role of migraine headache severity, associated features and interactions with overweight/obesity in inhibitory control.Obesity and paediatric migraine.
P2860
Q28066018-DEE099A6-2ECB-44D4-8FED-86EC17B0EF4EQ34162706-B3E90DB9-60DC-4BA3-97EB-E0AFA2BFE16BQ34279909-7CB30804-F733-447E-92D2-5F4E499F8BD7Q34645695-B8C8577C-C356-41AE-8A0E-0C6CE1CB7EF0Q34777915-BEC19C11-6585-4CCD-BA54-B3D34B02C963Q35276771-117BA71A-5DB9-417A-9B40-8DA380023CA6Q35400463-7F20442B-F8DB-4CE3-AE44-F8755C851402Q35901235-C6B87515-EAF8-4DCC-ACD7-E87312AA1B7BQ36696303-7C91D504-E2F8-4C93-B2CC-7A0F6FCBAC27Q36844703-B73A46FB-CA87-493D-BC85-CD3E322F6D22Q37610175-A38790F8-8887-4C2C-AB84-83B7441F7292Q37618928-673F022B-7DA4-416C-AEE6-9168D96D0E3AQ37678917-51E50106-4B18-4284-8781-7DF6C7619245Q37684467-5BDA2323-BAC9-4B2E-AEB3-C2F8076ED5C4Q37686431-7F7281EE-4393-41F8-80BA-5C76B78E7B0AQ37717848-C20159BE-49A0-44FE-9AB0-7A5A522562B4Q38014288-E9946CCC-5BD4-4FDD-87B6-FB254735FCCCQ38693579-1B2FC6D7-1909-4E25-BAF3-B89629502C33Q43549561-6E052EC4-9CBD-42B6-B941-EDB661471001Q44020787-2EB307F4-BE1A-41F9-A00D-A66A1ABA17EDQ46627574-7F9911CF-524F-4EF9-BC66-1BB8BA30FEABQ48044181-BF60EB89-DD99-43E8-AF9F-D6B49F9B7729Q49437735-6E000AA1-66A9-41FF-A443-560870689E36Q50072786-F9F098DC-89F9-43C1-837E-CEEC88C49512Q50506131-79AB380D-43B0-430A-8639-031AC4F89B7BQ51634613-DBFF9A1C-1006-4A92-A06C-BC556A4EFC74
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Migraine and adiponectin: is there a connection?
@en
type
label
Migraine and adiponectin: is there a connection?
@en
prefLabel
Migraine and adiponectin: is there a connection?
@en
P2093
P2860
P1433
P1476
Migraine and adiponectin: is there a connection?
@en
P2093
Peterlin BL
Rapoport AM
Sheftell FD
P2860
P304
P356
10.1111/J.1468-2982.2007.01306.X
P407
P577
2007-05-01T00:00:00Z